Connor, Clark & Lunn Investment Management (CC&L)’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.16M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.87M | Sell |
|
|||||
|
2024
Q1 | $2.7M | Sell |
|
|||||
|
2023
Q4 | $2.47M | Sell |
|
|||||
|
2023
Q3 | $2.33M | Sell |
|
|||||
|
2023
Q2 | $4.51M | Buy |
|
|||||
|
2023
Q1 | $2.81M | Sell |
|
|||||
|
2022
Q4 | $2.12M | Buy |
|
|||||
|
2022
Q3 | $1.61M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $505K | Buy |
|